Discovery of novel benzbromarone analogs with improved pharmacokinetics and benign toxicity profiles as antihyperuricemic agents.
Zhao Z, Liu J, Yuan L, Yang Z, Kuang P, Liao H, Luo J, Feng H, Zheng F, Chen Y, Wu T, Guo J, Cao Y, Yang Y, Lin C, Zhang Q, Chen J, Pang J.
Zhao Z, et al. Among authors: zheng f.
Eur J Med Chem. 2022 Nov 15;242:114682. doi: 10.1016/j.ejmech.2022.114682. Epub 2022 Aug 18.
Eur J Med Chem. 2022.
PMID: 36001935